YARROW BIOSCIENCE, INC. Increase (Decrease) in Inventories
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2024-03-01
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for the quarter ending 2023-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for the quarter ending 2023-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for the quarter ending 2023-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for the quarter ending 2023-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for fiscal 2023 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for fiscal 2022 was -$97.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for fiscal 2021 was -$113.00K, a 101.87% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. increase (decrease) in inventories for fiscal 2020 was $6.05M, a 346.02% increase from fiscal 2019.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $0.00 10-K · filed 2024-03-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-03-01 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $0.00 derived: sum of 4 quarters · filed 2024-03-01 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | $0.00 derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $0.00 derived: sum of 3 quarters · filed 2024-03-01 | -$97.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | -$97.00K 10-Q · filed 2023-11-13 | -$876.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$97.00K 10-Q · filed 2023-08-14 | -$876.00K derived: sum of 3 quarters · filed 2023-08-14 | -$1.08M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$97.00K 10-Q · filed 2023-05-11 | -$876.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.08M derived: sum of 3 quarters · filed 2023-05-11 | -$898.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$988.00K derived: sum of 2 quarters · filed 2023-03-14 | -$801.00K derived: sum of 3 quarters · filed 2023-03-14 | -$113.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$22.00K derived: sum of 2 quarters · filed 2022-11-14 | $666.00K 10-Q · filed 2022-11-14 | $1.42M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $875.00K 10-Q · filed 2022-08-12 | $1.63M derived: sum of 3 quarters · filed 2022-08-12 | $2.48M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $688.00K 10-Q · filed 2022-05-12 | $1.44M derived: sum of 2 quarters · filed 2022-05-12 | $2.29M derived: sum of 3 quarters · filed 2022-05-12 | $4.89M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.60M derived: sum of 2 quarters · filed 2022-03-17 | $4.20M derived: sum of 3 quarters · filed 2022-03-17 | $6.05M 10-K · filed 2022-03-17 |
| 2020-09-30 | $849.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.44M derived: sum of 2 quarters · filed 2021-11-10 | $5.29M 10-Q · filed 2021-11-10 | $6.65M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.45M 10-Q · filed 2021-08-12 | $5.80M derived: sum of 3 quarters · filed 2021-08-12 | $5.80M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.85M 10-Q · filed 2021-05-06 | $3.21M derived: sum of 2 quarters · filed 2021-05-06 | $3.21M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.36M derived: sum of 2 quarters · filed 2021-03-04 | $1.36M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |